Targeting Synaptic Actin: A Strategy to Combat Cognitive Decline in Alzheimer’s Disease
Synaptic dysfunction, marked by synapse loss and structural changes, is a key contributor to cognitive decline in Alzheimer’s disease (AD). This dysfunction is linked to…
CURATED BY: Eric Carlon, APRN, PMHNP-BC
Eric Carlon,
APRN, PMHNP-BC
Psychiatric Mental Health Nurse Practitioner, Home Physicians Group, Nova Southeastern University, Eastern Kentucky University, and Southern Adventist University
Gene Therapy: A Promising Frontier in Alzheimer’s Treatment and Disease Progression
Alzheimer’s disease (AD) remains a significant challenge due to its complex pathology and limited effectiveness of current treatments. Recent advances...
Exploring Shared Pathways: Anti-Cancer Drugs for Alzheimer’s Disease Management
Alzheimer's disease (AD) and cancer exhibit several shared biological features, such as angiogenesis, mitochondrial dysfunction, and proteostasis, highlighting potential therapeutic...
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive impairments that affect memory, decision-making, communication, and other aspects...